News Focus
News Focus
icon url

BuddyGuise

03/10/14 12:55 PM

#95485 RE: LOTHAR #95471

Obviously, you are your own person and the only person you have to listen to. I know many dd longs that are disappointed that we didn't hold near the high, but this is the Wild West of the stock market. That being said, I think this company is still grossly undervalued with a current market cap of only 300 million. Why do I say this, because an independent valuation company came and looked at everything ELTP, and with what they saw dating back to August 2013, was a company with a mean valuation of $2.10.....fully diluted. That would put the cap around $1.4 B. With the news yet to come out this month; patent by 3/18, third and possibly fourth trials starting this month, and the wild card of a partnership coming at anytime, I believe it is short sighted to let shares go at the current pps. A 300% gain is good and great, but we already touched .97 and I think we'll be back to those levels and beyond here shortly. GLTU
icon url

Couch

03/10/14 2:22 PM

#95545 RE: LOTHAR #95471

Just curious. If you know the company and done your DD- you must know how lucrative Elite's ART opioids will be when they hit the market. Also, a partner is likely to be PR'd soon. Why would you sell now?